Dr Anne-Sophie Bergot

Dr Anne-Sophie Bergot is an expert in Immune Regulation & Microbiome at University of Queensland, Translational Research Institute, Brisbane, Australia. She was awarded a Jian Zhou Research Excellence Award in 2017 and promoted to the faculty position of Research Fellow in 2018. She is leading research projects in Spondyloarthritis.

After receiving her PhD on immune regulation in cancer from La Sorbonne Universitas in France, Dr Anne-Sophie Bergot debuted in Australia working on HPV-associated cancers with Professor Ian Frazer. She then continued her journey working on autoimmune diseases, mentored by Prof. Ranjeny Thomas. In T1D, her pre-clinical work set the basis for the first-in-human trial of a liposome-based vaccine strategy, starting in 2023. Since 2019, her interest is focused on deciphering the link between the gut microbiome, the immune system and the development of autoimmune arthritis, for which she was awarded an ARA project grant in 2022.